- Home
- HSCS vs SINT Comparison
HSCS vs SINT Comparison
Compare HSCS & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HSCS | SINT |
|---|---|---|
| Founded | 2007 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0M | 12.5M |
| IPO Year | 2022 | 2014 |
Fundamental Metrics
Financial Performance| Metric | HSCS | SINT |
|---|---|---|
| Price | $3.16 | $2.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $9.20 | ★ $16.00 |
| AVG Volume (30 Days) | 30.5K | ★ 32.1K |
| Earning Date | 03-12-2026 | 03-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $8,669.00 | ★ $1,270,000.00 |
| Revenue This Year | $1,072.41 | N/A |
| Revenue Next Year | $2,700.00 | $80.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.01 | $1.71 |
| 52 Week High | $6.47 | $7.36 |
Technical Indicators
Market Signals| Indicator | HSCS | SINT |
|---|---|---|
| Relative Strength Index (RSI) | 49.07 | 26.38 |
| Support Level | $2.72 | $2.73 |
| Resistance Level | $3.25 | $3.09 |
| Average True Range (ATR) | 0.19 | 0.14 |
| MACD | -0.03 | -0.04 |
| Stochastic Oscillator | 51.35 | 12.82 |
Price Performance
Historical ComparisonAbout HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
About SINT SiNtx Technologies Inc.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.